Sign Out
3.75 mg/11.25 mg: There is no clinical experience with the effects of an acute overdosage of leuprorelin acetate. In animal studies, doses of up to 500 times the recommended human dose resulted in dyspnea, decreased activity and local irritation at the injection sites. In cases of overdosage, the patients should be monitored closely and management should be symptomatic and supportive.
30 mg: To date, no symptoms of intoxication have been reported.
Even when administered in daily doses of up to 20 mg for a period of two years, like applied in the first clinical studies, no new side effects or side effects different from those observed with a daily dose of 1 mg or with a dose of 30 mg administered every 6 months have been reported.
Continue with Google